41 – 50 of 57
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Thymidylate synthase : A predictive biomarker in resected colorectal liver metastases receiving 5-FU treatment
(
- Contribution to journal › Article
-
Mark
Intratumoural leukocyte infiltration is a prognostic indicator among pancreatic cancer patients with type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Primary lymph node ratio and hepatic resection for colorectal metastases
(
- Contribution to journal › Debate/Note/Editorial
- 2017
-
Mark
Factors influencing receipt of adjuvant chemotherapy after surgery for pancreatic cancer : a two-center retrospective cohort study
(
- Contribution to journal › Article
-
Mark
Acute biliary pancreatitis: focus on recurrence rate and costs when current guidelines are not complied
(
- Contribution to journal › Article
-
Mark
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine
(
- Contribution to journal › Article
-
Mark
The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer : a systematic review of safety and efficacy
(
- Contribution to journal › Scientific review
-
Mark
Does next-generation sequencing of cyst fluid improve management of pancreatic cystic neoplasms?
(
- Contribution to journal › Scientific review
-
Mark
Development and In Vitro Characterization of a Gemcitabine-loaded MUC4-targeted Immunoliposome Against Pancreatic Ductal Adenocarcinoma
(
- Contribution to journal › Article